Search
Search Results
Found 13 items.
-
Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy
Published: December 31, 20132578PDF: 2016 -
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience
Published: December 31, 20171442PDF: 758 -
Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists
Published: March 19, 20241012PDF: 241 -
History of infantile BCG immunization did not predict lamina propria invasion and/or high-grade in patients with non-muscle invasive bladder cancer
Published: May 31, 2023628PDF: 374 -
Does intravesical bacillus Calmette-Guérin for bladder cancer protect from COVID-19?
Published: May 9, 2024639PDF: 225 -
Bacillus Calmette-Guerin vaccine and bladder cancer incidence: Scoping literature review and preliminary analysis
Published: March 18, 20211481PDF: 962Supplementary Material: 150 -
HER2/neu expression status of post BCG recurrent non-muscle-invasive bladder urothelial carcinomas in relation to their primary ones
Published: May 30, 2023877PDF: 367 -
Prognostic impact of ReTURB in high grade T1 primary bladder cancer
Published: July 4, 20162149PDF: 1255 -
Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer
Published: June 28, 20211052PDF: 427 -
-
New concept in urologic surgery: The total extended genital sparing radical cystectomy in women
Published: May 22, 20231519PDF: 647 -
1 - 13 of 13 items